Model-Based Optimization of a Fed-Batch Bioreactor for mAb Production Using a Hybridoma Cell Culture.

Gheorghe Maria
Author Information
  1. Gheorghe Maria: Department of Chemical and Biochemical Engineering, University Politehnica of Bucharest, Polizu Str. 1-7, P.O. 35-107, 011061 Bucharest, Romania. ORCID

Abstract

Production of monoclonal antibodies () is a well-known method used to synthesize a large number of identical antibodies, which are molecules of huge importance in medicine. Due to such reasons, intense efforts have been invested to maximize the production in bioreactors with hybridoma cell cultures. However, the optimal control of such sensitive bioreactors is an engineering problem difficult to solve due to the large number of state-variables with highly nonlinear dynamics, which often translates into a non-convex optimization problem that involves a significant number of decision (control) variables. Based on an adequate kinetic model adopted from the literature, this paper focuses on developing an in-silico (model-based, offline) numerical analysis of a fed-batch bioreactor () with an immobilized hybridoma culture to determine its optimal feeding policy by considering a small number of control variables, thus ensuring maximization of production. The obtained time stepwise optimal feeding policies of were proven to obtain better performances than those of simple batch operation () for all the verified alternatives in terms of raw material consumption and productivity. Several elements of novelty (i-iv) are pointed out in the "conclusions" section (e.g., considering the continuously added biomass as a control variable during ).

Keywords

References

  1. Biotechnol Bioeng. 1995 Jan 5;45(1):18-26 [PMID: 18623047]
  2. J Biotechnol. 2001 Feb 13;85(2):187-212 [PMID: 11165363]
  3. Bioengineering (Basel). 2018 Nov 21;5(4): [PMID: 30469407]
  4. J Biotechnol. 1990 Nov;16(3-4):259-78 [PMID: 1366938]
  5. Bioprocess Biosyst Eng. 2005 Jul;27(4):255-62 [PMID: 15928931]
  6. Int J Mol Sci. 2018 Jan 28;19(2): [PMID: 29382079]
  7. Crit Rev Biotechnol. 2010 Jun;30(2):145-59 [PMID: 20210690]
  8. Comput Struct Biotechnol J. 2013 Mar 10;3:e201210022 [PMID: 24688682]
  9. Biotechnol Bioeng. 1991 Oct 20;38(8):821-30 [PMID: 18600839]
  10. Bioengineering (Basel). 2017 Feb 23;4(1): [PMID: 28952495]
  11. Biotechnol Adv. 2005 Nov;23(7-8):471-99 [PMID: 15919172]
  12. J Biosci Bioeng. 2012 Feb;113(2):233-8 [PMID: 22078279]
  13. Bioprocess Biosyst Eng. 2014 Aug;37(8):1637-52 [PMID: 24519722]
  14. J Biotechnol. 2017 Feb 20;244:34-44 [PMID: 28137617]
  15. Biotechnol Bioeng. 1998 Mar 20;57(6):642-54 [PMID: 10099244]
  16. MAbs. 2010 Sep-Oct;2(5):466-79 [PMID: 20622510]
  17. Biotechnol Bioeng. 1988 Oct 5;32(8):1067-72 [PMID: 18587824]
  18. Bioinformatics. 2006 Nov 15;22(22):2790-9 [PMID: 16954140]
  19. Metab Eng. 2018 May;47:21-30 [PMID: 29501926]
  20. Cytotechnology. 1994;16(1):1-15 [PMID: 7765785]

MeSH Term

Animals
Antibodies, Monoclonal
Batch Cell Culture Techniques
Bioreactors
Hybridomas
Kinetics
Mice
Models, Biological

Chemicals

Antibodies, Monoclonal

Word Cloud

Created with Highcharts 10.0.0numbercontrolantibodieshybridomaoptimalProductionmonoclonallargeproductionbioreactorscellproblemdynamicsoptimizationvariablesfed-batchbioreactorculturefeedingpolicyconsideringmaximizationtimestepwiserawmaterialconsumptionwell-knownmethodusedsynthesizeidenticalmoleculeshugeimportancemedicineDuereasonsintenseeffortsinvestedmaximizeculturesHoweversensitiveengineeringdifficultsolveduestate-variableshighlynonlinearoftentranslatesnon-convexinvolvessignificantdecisionBasedadequatekineticmodeladoptedliteraturepaperfocusesdevelopingin-silicomodel-basedofflinenumericalanalysisimmobilizeddeterminesmallthusensuringobtainedpoliciesprovenobtainbetterperformancessimplebatchoperationverifiedalternativestermsproductivitySeveralelementsnoveltyi-ivpointed"conclusions"sectionegcontinuouslyaddedbiomassvariableModel-BasedOptimizationFed-BatchBioreactormAbUsingHybridomaCellCulturemAbsoperating

Similar Articles

Cited By (3)